Related Experiment Videos
Potassium channel blockers: could they work in Alzheimer disease?
1Department of Psychiatry, University of California, Los Angeles 90024.
Alzheimer Disease and Associated Disorders
|January 1, 1991
Abstract:
Many of the actions of potassium channel blockers, such as 4-aminopyridine, appear to complement the deficits in Alzheimer disease. The two clinical studies in the literature are contradictory, so potassium channel blockers may still merit trial in Alzheimer disease.